Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$407K Sell
3,445
-113
-3% -$13K ﹤0.01% 506
2026
Q1
$425K Buy
3,558
+144
+4% +$18.9K ﹤0.01% 484
2025
Q4
$465K Sell
3,414
-14
-0.4% -$2.01K 0.01% 453
2025
Q3
$506K Sell
3,428
-100
-3% -$13.9K 0.01% 441
2025
Q2
$456K Sell
3,528
-21
-0.6% -$2.54K 0.01% 442
2025
Q1
$424K Sell
3,549
-112
-3% -$13.9K 0.01% 429
2024
Q4
$425K Buy
3,661
+1
+0% +$126 0.01% 433
2024
Q3
$494K Buy
3,660
+1,172
+47% +$157K 0.01% 404
2024
Q2
$337K Buy
2,488
+35
+1% +$4.76K ﹤0.01% 438
2024
Q1
$317K Buy
2,453
+168
+7% +$20.3K ﹤0.01% 446
2023
Q4
$261K Buy
+2,285
New +$228K ﹤0.01% 459

Other funds holding XYL

RWA Wealth Partners's XYL Position: Q2 2026 in Review

RWA Wealth Partners reduced its Xylem (XYL) stake by 3.2% in Q2 2026, selling an estimated $13K and leaving 3,445 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #506.

RWA Wealth Partners first reported a position in XYL in Q4 2023 and has held it in 11 quarters since. The position peaked at $506K in Q3 2025. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • RWA Wealth Partners held 3,445 shares of Xylem worth $407K as of Q2 2026.
  • RWA Wealth Partners sold 113 Xylem shares in Q2 2026, an estimated $13K.
  • Xylem made up ﹤0.01% of RWA Wealth Partners's portfolio in Q2 2026, its #506 holding.
  • RWA Wealth Partners first reported a position in Xylem in Q4 2023 and has held it in 11 quarters since.
  • RWA Wealth Partners's Xylem position peaked at $506K in Q3 2025.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on RWA Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.